Stay updated with breaking news from Executive Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, Feb 8 — Pfizer said today it expects US$32 billion (RM152 billion) in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to US$22 billion. The pharmaceutical giant, which with German company BioNTech won approval for the first vaccine to counter...
Pfizer said Tuesday it expects US$32bn in revenue from COVID-19 vaccines in 2022 as it reported annual profits had more than doubled to US$22bn.
Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of…
Pfizer also expects $22 billion in sales of Paxlovid, the company's pill for COVID-19, in 2022.
